Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fixed-dose combination therapy for psoriasis.

Lyn C Guenther1

  • 1The Guenther Dermatology Research Centre, London, Ontario, Canada. dgue@uwo.ca

American Journal of Clinical Dermatology
|April 28, 2004
PubMed
Summary

Fixed-dose combination therapies, including betamethasone dipropionate with salicylic acid or calcipotriene, offer effective and convenient topical treatments for psoriasis. These combinations demonstrate comparable or superior efficacy and faster symptom relief than individual components.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Journal of cutaneous medicine and surgery·2023
Same author

Leveraging Blockchain Technology for Informed Consent Process and Patient Engagement in a Clinical Trial Pilot.

Blockchain in healthcare today·2023
Same author

Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis.

Dermatology and therapy·2022
Same author

Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemic.

SAGE open medicine·2021
Same author

Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study.

The Journal of dermatological treatment·2021
Same author

Comparison of topical antiaging creams in the management of lateral canthal lines.

Journal of cosmetic dermatology·2019

Area of Science:

  • Dermatology
  • Pharmacology
  • Drug Development

Background:

  • Topical corticosteroids are primary treatments for psoriasis.
  • Fixed-dose combination (FDC) therapies offer convenience and potentially enhanced efficacy.
  • Psoriasis management benefits from treatments with distinct mechanisms of action.

Purpose of the Study:

  • To evaluate the efficacy and safety of FDC topical therapies for psoriasis.
  • To compare FDCs containing betamethasone dipropionate with other treatments.
  • To highlight the advantages of FDC therapy in psoriasis management.

Main Methods:

  • Review of clinical studies comparing FDCs (e.g., betamethasone dipropionate + salicylic acid, betamethasone dipropionate + calcipotriene) with monotherapies and other combinations.

Related Experiment Videos

  • Analysis of efficacy data including Psoriasis Area and Severity Index (PASI) scores and symptom improvement.
  • Assessment of safety profiles and adverse cutaneous events.
  • Main Results:

    • Betamethasone dipropionate + salicylic acid showed comparable efficacy to clobetasol and calcipotriene ointments, and clobetasol lotion.
    • Betamethasone dipropionate + salicylic acid lotion provided faster relief of scaling, itching, and redness than betamethasone dipropionate alone.
    • Betamethasone dipropionate + calcipotriene demonstrated superior efficacy and faster onset than individual components, with significant PASI reductions and fewer adverse events compared to calcipotriene and tacalcitol.

    Conclusions:

    • Fixed-dose combination topical therapies, particularly those containing betamethasone dipropionate, are effective and well-tolerated options for psoriasis treatment.
    • FDCs offer advantages in terms of efficacy, speed of onset, and patient convenience.
    • These combinations represent valuable advancements in psoriasis management strategies.